Id |
Subject |
Object |
Predicate |
Lexical cue |
T826 |
0-31 |
Sentence |
denotes |
Animal Models and Cell Cultures |
T827 |
32-255 |
Sentence |
denotes |
For evaluating the potential of vaccines and therapeutics against CoVs, including SARS-CoV, MERS-CoVs, and the presently emerging SARS-CoV-2, suitable animal models that can mimic the clinical disease are needed (211, 212). |
T828 |
256-464 |
Sentence |
denotes |
Various animal models were assessed for SARS- and MERS-CoVs, such as mice, guinea pigs, golden Syrian hamsters, ferrets, rabbits, nonhuman primates like rhesus macaques and marmosets, and cats (185, 213–218). |
T829 |
465-592 |
Sentence |
denotes |
The specificity of the virus to hACE2 (receptor of SARS-CoV) was found to be a significant barrier in developing animal models. |
T830 |
593-716 |
Sentence |
denotes |
Consequently, a SARS-CoV transgenic mouse model has been developed by inserting the hACE2 gene into the mouse genome (219). |
T831 |
717-850 |
Sentence |
denotes |
The inability of MERS-CoV to replicate in the respiratory tracts of animals (mice, hamsters, and ferrets) is another limiting factor. |
T832 |
851-1043 |
Sentence |
denotes |
However, with genetic engineering, a 288-330+/+ MERS-CoV genetically modified mouse model was developed and now is in use for the assessment of novel drugs and vaccines against MERS-CoV (220). |
T833 |
1044-1308 |
Sentence |
denotes |
In the past, small animals (mice or hamsters) have been targeted for being closer to a humanized structure, such as mouse DPP4 altered with human DPP4 (hDPP4), hDPP4-transduced mice, and hDPP4-Tg mice (transgenic for expressing hDPP4) for MERS-CoV infection (221). |
T834 |
1309-1452 |
Sentence |
denotes |
The CRISPR-Cas9 gene-editing tool has been used for inserting genomic alterations in mice, making them susceptible to MERS-CoV infection (222). |
T835 |
1453-1829 |
Sentence |
denotes |
Efforts are under way to recognize suitable animal models for SARS-CoV2/COVID-19, identify the receptor affinity of this virus, study pathology in experimental animal models, and explore virus-specific immune responses and protection studies, which together would increase the pace of efforts being made for developing potent vaccines and drugs to counter this emerging virus. |
T836 |
1830-2097 |
Sentence |
denotes |
Cell lines, such as monkey epithelial cell lines (LLC-MK2 and Vero-B4), goat lung cells, alpaca kidney cells, dromedary umbilical cord cells, and advanced ex vivo three-dimensional tracheobronchial tissue, have been explored to study human CoVs (MERS-CoV) (223, 224). |
T837 |
2098-2192 |
Sentence |
denotes |
Vero and Huh-7 cells (human liver cancer cells) have been used for isolating SARS-CoV-2 (194). |
T838 |
2193-2470 |
Sentence |
denotes |
Recently, an experimental study with rhesus monkeys as animal models revealed the absence of any viral loads in nasopharyngeal and anal swabs, and no viral replication was recorded in the primary tissues at a time interval of 5 days post-reinfection in reexposed monkeys (274). |
T839 |
2471-2674 |
Sentence |
denotes |
The subsequent virological, radiological, and pathological observations indicated that the monkeys with reexposure had no recurrence of COVID-19, like the SARS-CoV-2-infected monkeys without rechallenge. |
T840 |
2675-2924 |
Sentence |
denotes |
These findings suggest that primary infection with SARS-CoV-2 could protect from later exposures to the virus, which could help in defining disease prognosis and crucial inferences for designing and developing potent vaccines against COVID-19 (274). |